How Would You Treat a High Risk Patient with CVD Who is Receiving Chemotherapy

The expert talk focuses on managing cardiovascular risk in patients undergoing potentially cardiotoxic cancer therapies. The talk emphasizes the importance of baseline risk assessment using tools like the HFA-ICOS to stratify patients. It covers risk factors for Cancer Treatment-Related Cardiovascular Toxicity (CTR-CVT) and provides guidance on monitoring and follow-up strategies throughout the cancer therapy continuum. The presentation also details the critical role of cardio-oncology teamwork... Read more